CC
VIR icon

Corton Capital’s Vir Biotechnology VIR Stock Holding History

Corton Capital’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,527
Closed -$114K – 416
2025
Q2 		$114K Buy
+22,527
New +$121K 0.13% 304
2024
Q4 		– Sell
-102,400
Closed -$767K – 660
2024
Q3 		$767K Buy
102,400
+57,987
+131% +$504K 0.37% 13
2024
Q2 		$395K Sell
44,413
-4,058
-8% -$38.9K 0.21% 101
2024
Q1 		$491K Buy
48,471
+4,893
+11% +$49.8K 0.18% 140
2023
Q4 		$438K Buy
+43,578
New +$398K 0.14% 201
2022
Q2 		– Sell
-19,098
Closed -$491K – 523
2022
Q1 		$491K Buy
19,098
+4,062
+27% +$120K 0.21% 121
2021
Q4 		$630K Buy
+15,036
New +$589K 0.28% 69

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Corton Capital's VIR Position: Q3 2025 in Review

Corton Capital sold out of Vir Biotechnology (VIR) in Q3 2025, closing a stake of 22,527 shares — an estimated $114K sold.

Corton Capital first reported a position in VIR in Q4 2021 and held it in 7 quarters. The position peaked at $767K in Q3 2024. 213 funds tracked by Wall St. Rank hold VIR as of Q3 2025.

  • Corton Capital reported no remaining Vir Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Corton Capital sold 22,527 Vir Biotechnology shares in Q3 2025, an estimated $114K.
  • Corton Capital first reported a position in Vir Biotechnology in Q4 2021 and held it in 7 quarters.
  • Corton Capital's Vir Biotechnology position peaked at $767K in Q3 2024.
  • 213 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.